KAYNAKLAR
1. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. Journal of allergy and clinical immunology. 1993;91(3):734-737.
2. Lower T, Henry J, Mandik L, Janosky J, Friday Jr G. Compliance with allergen immunotherapy. Annals of allergy. 1993;70(6):480.
3. Incorvaia C, Mauro M, Ridolo E, et al. Patient’s compliance with allergen immunotherapy. Patient preference and adherence. 2008;2:247.
4. Vita D, Caminiti L, Arrigo T, Lombardo F, Incorvaia C, ni Barberio G. Children’s compliance with allergen immunotherapy according to administration routes. Journal of allergy and clinical immunology. 2005;116(6):1380.
5. Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Human vaccines & immunotherapeutics. 2017;13(3):514-517.
6. Cox LS, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter.The Journal of Allergy and Clinical Immunology: In Practice.2014;2(2):156-160. e152.
7. De Filippo O, D’Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. New England Journal of Medicine.2020.
8. Brożek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Journal of Allergy and Clinical Immunology. 2010;126(3):466-476.
9. Pedersen SE, Hurd SS, Lemanske Jr RF, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatric pulmonology.2011;46(1):1-17.
10. Bilo B, Rueff F, Mosbech H, Bonifazi F, Oude‐Elberink J, Hypersensitivity EIGoIV. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60(11):1339-1349.
11. Golden DB. Insect sting allergy and venom immunotherapy: a model and a mystery. Journal of allergy and clinical immunology. 2005;115(3):439-447.
12. Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. Journal of Allergy and Clinical Immunology. 2015;136(3):556-568.
13. Chaker A, Al-Kadah B, Luther U, Neumann U, Wagenmann M. An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial. Clinical and translational allergy.2015;6(1):1-7.
14. Leader BA, Rotella M, Stillman L, DelGaudio JM, Patel ZM, Wise SK. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy. Paper presented at: International forum of allergy & rhinology2016.
15. Yang Y, Wang Y, Yang L, et al. Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real‐life study. Paper presented at: International Forum of Allergy & Rhinology2018.
16. Donahue JG, Greineder DK, Connor-Lacke L, Canning CF, Platt R. Utilization and cost of immunotherapy for allergic asthma and rhinitis. Annals of Allergy, Asthma & Immunology. 1999;82(4):339-347.
17. Mahesh P, Vedanthan P, Amrutha D, Giridhar B, Prabhakar A. Factors associated with non-adherence to specific allergen immunotherapy in management of respiratory allergy.The Indian journal of chest diseases & allied sciences.2010;52(2):91.
18. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Annals of Allergy, Asthma & Immunology.2002;88(4):391-394.
19. Lourenco T, Fernandes M, Coutinho C, Lopes A, Neto M. Subcutaneous immunotherapy with aeroallergens Evaluation of adherence in real life. European annals of allergy and clinical immunology. 2020;52(2):84-90.
20. Gelincik A, Demir S, Olgaç M, et al. High adherence to subcutaneous immunotherapy in a real-life study from a large tertiary medical center. Paper presented at: Allergy & Asthma Proceedings2017.
21. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy.Annals of Allergy, Asthma & Immunology. 1999;82(3):281-286.
22. Çetinkaya PG, Esenboğa S, Soyer ÖU, Tuncer A, Şekerel BE, Şahiner ÜM. Subcutaneous venom immunotherapy in children: Efficacy and safety. Annals of Allergy, Asthma & Immunology. 2018;120(4):424-428.
23. Gur Cetinkaya P, Kahveci M, Esenboğa S, et al. Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children. Pediatric Allergy and Immunology. 2020.
24. Kilincel S KO, Muratdagi G, Aydin A, Usta MB. Factors affecting the anxiety levels of adolescents in home‐quarantine during COVID‐19 pandemic in Turkey. Asia Pacific Psychiatry. 2020 Aug 2011;e12406.
25. Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health. 2020.